Global Veterinary Clostridium Vaccine Market is Expected to Register a Healthy CAGR in the Forecast Period of 2019 to 2026

According to Data Bridge Market Research new Market report, global veterinary clostridium vaccine market will account to an estimated USD 494.65 million in 2018 growing at a CAGR of 4.72% during the forecast period of 2019 to 2026.

Access Full Report at

Global Veterinary Clostridium Vaccine Market

Veterinary clostridium vaccine is a type of treatment or vaccine for the treatment of clostridial diseases and pneumonia in livestock. This vaccine results in the livestock being able to produce specific set of antibodies in the body. These sets of antibodies are then subsequently released into the mammary glands and make the body immune towards clostridial diseases.

Segmentation: Global Veterinary Clostridium Vaccine Market

Global veterinary clostridium vaccine market is segmented on the basis of animal species, distribution channel and geography.

By Animal Species (Bovine, Ovine, Caprine, Swine, Poultry, Others), Distribution Channel (Veterinary Clinic, Veterinary Hospital, Veterinary Research Institute, Retail Pharmacy) and Geography (North America, South America, Europe, Asia-Pacific, Middle East & Africa)


Growth in production of products dependent on livestock

According to Food and Agriculture Organization, there has been a constant rise in the production of commodities that are dependent on or produced through livestock. In 1997/99 around 218 million tonnes of total meat was produced by the world. This number rose to 300 million tonnes by 2015. This number is projected to rise to 376 million tonnes by 2030, requiring that the livestock and animals being produced be healthy and without any diseases. This factor and growth in the production of meat is expected to positively grow the market value for veterinary clostridium vaccine.

Global Veterinary Clostridium Vaccine Market

Key Market Competitors:

Few of the major competitors currently working in the veterinary clostridium vaccine market are Bayer AG, Bimeda, Inc., Boehringer Ingelheim International GmbH., Ceva , Eli Lilly and Company, Intervet Inc., a subsidiary of Merck & Co. Inc., Sanofi, Virbac, Zoetis, Inc., Aratana Therapeutics, Inc., ARKO Labs, CanFel Therapeutics, CEVA Logistics, Hygieia Biological Laboratories, Nuovo Biologics,LLC, and Valneva SE,.

Browse Related Reports:

Global Veterinary Equipment and Disposables Market, By Type (Critical Care Consumables, Anesthesia Equipment, Fluid Management Equipment, Temperature Management Equipment, Patient Monitoring Equipment, Research Equipment, Rescue & Resuscitation Equipment), By Animal Type (Small Companion Animals, Large Animals, Other Animals), By End User (Veterinary Clinics, Veterinary Hospitals, Research Institutes)– Industry Trends and Forecast to 2025

Global Veterinary CT scanner Market, By Type (Stationary Multi-Slice CT Scanners and Portable CT Scanners), Animal Type (Small Companion Animals, Equine and Livestock and others), Application (Neurology, Oncology, Orthopaedics and Traumatology and others), End Users (Veterinary Hospitals and Clinics, Research Institute), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)– Industry Trends and Forecast to 2025

Global Veterinary Endoscopy Market, By Product Type (Flexible, Videoscope, Fibreoptic, Rigid), Procedure (Bronchoscopy, Laparoscopy, Gastroduodenoscopy, Colonoscopy, Rhinoscopy), Animal (Companion, Large), End User (Hospitals, Clinics), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)– Industry Trends and Forecast to 2025